Mark Gohdes

469 total citations
13 papers, 353 citations indexed

About

Mark Gohdes is a scholar working on Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark Gohdes has authored 13 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 3 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark Gohdes's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Mark Gohdes is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug Transport and Resistance Mechanisms (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Mark Gohdes collaborates with scholars based in United States and United Kingdom. Mark Gohdes's co-authors include Philip A. Krieter, Timothy J Musick, Rachel Courtney, Monika Martinho, Austin C. Li, Wilson Z. Shou, Leszek Poppe, Desmond Padhi, Hao Sun and Gondi Kumar and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Pharmacology and Experimental Therapeutics and Drug Metabolism and Disposition.

In The Last Decade

Mark Gohdes

13 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Gohdes United States 8 139 100 80 67 47 13 353
Masataka Katashima Japan 13 104 0.7× 119 1.2× 108 1.4× 104 1.6× 89 1.9× 46 513
Rajendra Singh United States 11 83 0.6× 63 0.6× 116 1.4× 27 0.4× 89 1.9× 33 383
Jutta Miller United States 12 86 0.6× 42 0.4× 64 0.8× 49 0.7× 36 0.8× 20 483
Arvind B. Rege United States 12 98 0.7× 56 0.6× 65 0.8× 39 0.6× 39 0.8× 16 503
Venkateswaran C. Pillai United States 12 55 0.4× 55 0.6× 106 1.3× 68 1.0× 151 3.2× 22 487
Mark Allison United States 9 115 0.8× 81 0.8× 171 2.1× 44 0.7× 137 2.9× 14 514
Daria Stypinski United States 14 55 0.4× 39 0.4× 81 1.0× 125 1.9× 169 3.6× 30 562
Grant T. Generaux United States 9 174 1.3× 50 0.5× 88 1.1× 173 2.6× 160 3.4× 10 486
Melanie de la Cruz United States 6 83 0.6× 42 0.4× 108 1.4× 55 0.8× 234 5.0× 7 401
Derrick G. Freitag Canada 13 29 0.2× 31 0.3× 102 1.3× 28 0.4× 32 0.7× 21 391

Countries citing papers authored by Mark Gohdes

Since Specialization
Citations

This map shows the geographic impact of Mark Gohdes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Gohdes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Gohdes more than expected).

Fields of papers citing papers by Mark Gohdes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Gohdes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Gohdes. The network helps show where Mark Gohdes may publish in the future.

Co-authorship network of co-authors of Mark Gohdes

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Gohdes. A scholar is included among the top collaborators of Mark Gohdes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Gohdes. Mark Gohdes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zheng, Jim, Bing Lu, Gavin Carr, et al.. (2024). Lenacapavir Exhibits Atropisomerism—Mechanistic Pharmacokinetics and Disposition Studies of Lenacapavir Reveal Intestinal Excretion as a Major Clearance Pathway. Journal of Pharmacology and Experimental Therapeutics. 391(1). 91–103. 6 indexed citations
2.
Khetarpal, Vinod, Steven R. Ash, Michael E. Fitzsimmons, et al.. (2021). Pharmacokinetics and metabolic disposition of a potent and selective kynurenine monooxygenase inhibitor, CHDI-340246, in laboratory animals. Xenobiotica. 51(10). 1155–1180. 1 indexed citations
3.
Cashman, John R., et al.. (2019). N-Oxygenation of Oxycodone and Retro-reduction of Oxycodone N-Oxide. Drug Metabolism and Disposition. 48(2). 106–115. 5 indexed citations
4.
Podoll, Terry, Paul G. Pearson, Jerry Evarts, et al.. (2018). Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans. Drug Metabolism and Disposition. 47(2). 145–154. 50 indexed citations
5.
Lou, Zhen, et al.. (2018). Metabolism of 14C-SRD005825 in mouse, rat, dog, monkey, and human hepatic microsomes. Drug Metabolism and Pharmacokinetics. 33(1). S81–S81. 1 indexed citations
6.
Woodward, Caroline, Himanshu Naik, Mark Versavel, et al.. (2018). Phase 1 study to evaluate the absorption, metabolism and excretion of the NAV1.7-selective sodium channel blocker BIIB074. Drug Metabolism and Pharmacokinetics. 33(1). S74–S74. 4 indexed citations
7.
8.
Musick, Timothy J, et al.. (2007). Pharmacokinetics, Disposition, and Metabolism of Bicifadine in the Mouse, Rat, and Monkey. Drug Metabolism and Disposition. 36(2). 241–251. 12 indexed citations
9.
Krieter, Philip A., Mark Gohdes, Timothy J Musick, Frederick P. Duncanson, & William E. Bridson. (2007). Pharmacokinetics, Disposition, and Metabolism of Bicifadine in Humans. Drug Metabolism and Disposition. 36(2). 252–259. 17 indexed citations
10.
Erickson, David A., et al.. (2007). In Vitro Metabolism of the Analgesic Bicifadine in the Mouse, Rat, Monkey, and Human. Drug Metabolism and Disposition. 35(12). 2232–2241. 12 indexed citations
11.
Major, Michael A., et al.. (2007). Metabolite Profiling of [14C]hexahydro-1, 3, 5-trinitro-1,3,5-triazine (RDX) in Yucatan Miniature Pigs. Journal of Toxicology and Environmental Health. 70(14). 1191–1202. 7 indexed citations
12.
Kumar, Gondi, et al.. (2004). METABOLISM AND DISPOSITION OF CALCIMIMETIC AGENT CINACALCET HCL IN HUMANS AND ANIMAL MODELS. Drug Metabolism and Disposition. 32(12). 1491–1500. 48 indexed citations
13.
Krieter, Philip A., et al.. (2004). Disposition of Posaconazole following Single-Dose Oral Administration in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 48(9). 3543–3551. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masataka Katashima Breakdown of academic impact, for papers by Rajendra Singh Breakdown of academic impact, for papers by Jutta Miller Breakdown of academic impact, for papers by Arvind B. Rege Breakdown of academic impact, for papers by Venkateswaran C. Pillai Breakdown of academic impact, for papers by Mark Allison Breakdown of academic impact, for papers by Daria Stypinski Breakdown of academic impact, for papers by Grant T. Generaux Breakdown of academic impact, for papers by Melanie de la Cruz Breakdown of academic impact, for papers by Derrick G. Freitag
Rankless by CCL
2026